CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
87 hedge funds and large institutions have $1.53B invested in China Biologic Products Holdings, Inc. in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 91 → 87 (-4)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
Holders
87
Holding in Top 10
7
Calls
$20.9M
Puts
$4.6M
Top Buyers
| 1 | +$55.6M | |
| 2 | +$24.4M | |
| 3 | +$19.7M | |
| 4 |
YCMGA
York Capital Management Global Advisors
New York
|
+$11.6M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$7.17M |
Top Sellers
| 1 | -$35.9M | |
| 2 | -$7.68M | |
| 3 | -$7.47M | |
| 4 |
MCP
Maso Capital Partners
Hong Kong
|
-$7.36M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$6.69M |